Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BioVaxys Technology Corp C.BIOV

Alternate Symbol(s):  BVAXF

BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 
@ the Bell: Energy & mining recover to lift TSX
Following a nasty session in the red, Canada’s main stock index rose more than 300 points in Friday trading. Gains were led by the energy and base metal sectors.After two brutal weeks brought... read article.
The Cannabis Report: June 24, 2022
Nextleaf to launch THC-O as an excise tax-free alternative to Delta-9-THC Nextleaf Solutions (OILS) has provided an update on the manufacturing of D9-tetrahydrocannabinol acetate,... read article.

UK SARS-CoV-2 cases up 105%

https://inews.co.uk/news/science/covid-cases-uk-omicon-ba4-ba5-variants-spread-1701842 This is not over...a pan sarbecovirus vax could be a paradigm changing development  rate and reply

BIOV GET THE SCUBA DIVING GEAR ON LONGS @.09 KABOOM

Ya gotta love the dips!!$$$  rate and reply
Buzz on the Bullboards: Another summer of uncertainty?
In times of uncertainty in the markets, investors tend to focus on more consistent plays.Not all investors are basking in summer vacations and backyard barbeques. For those who are still plugged... read article.

HELLO BIOV~TIE A PORK CHOP ASK@12 MAYBE SOMEBODY WILL PLAY

WITH US!! hahaha shout out LONGS!! NICE UPDATE thanks for posting  rate and reply

Nice update on BIOV from MedicalGold

https://www.medicalgold.ca/featured/innovative-solution-to-an-intractable-problem-immunotherapy-for-ovarian-cancer  rate and reply

RE:Covid Ba 4 5 not on vacation as BIOV develops uniiversal

This would be first of its kind.  rate and reply

RE:Covid Ba 4 5 not on vacation as BIOV develops uniiversal

if your wondering why there hasn't been much KanCer cures released... its because is a vitamin b17 deficiency... can get it in apricot kernels. Health Canada says to eat no more than 3 per day  rate and reply

Covid Ba 4 5 not on vacation as BIOV develops uniiversal

vaccine.  Strains upticking  globally as original vaccines wear off. VANCOUVER, BC, June 3, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (...read more

BIOV BEST PART OF THE NEWSWIRE

 With the surgically excised tumors we can now begin the final stages of the vaccine production protocol and GMP validation." BioVaxys' vaccine platform is based on the established...read more

BIOV I GOT MY FILL THANK YOU!! HAPPY FOR THOSE WHO GOT @.095

DANG RIGHT I'M happy as long as the shares are in strong hands and PROGRESS is continuing to move and shareholders are continuing to be informed....my money staying right here until I get what I...read more

BVX-0918/T cell video

Not sure how to post it here, but the BIOV twitter account has a really cool video from Cambridge Univ that explains how T cells kill tumors.   Stimulating  T cell response to tumors is...read more

Other market .13 buy

13:57:06 U 0.13 0.02 2,000 2 RBC  rate and reply

BIOV COME BACK HERE NOW~DATS ME ON BID@.10 FINISH MY FILL!!

PROGRESS...and more progress......that is all I am looking for in this ridiculous market. Any other time our sp would soar on this news. Great Job I see the FDA holding a trophy for us in the near off...read more

RE:News again BVX-0918 Vaccine Process Development

This is a critical stage, if successful hope we can see rapid progress.  rate and reply

News again BVX-0918 Vaccine Process Development

Clinical Study Collaborator HCL Sends First Surgically Excised Ovarian Cancer Tumors to BioVaxys for BVX-0918 Vaccine Process Development VANCOUVER, BC, June 15, 2022 /PRNewswire...read more

New Press Release - Clinical Study Collaborator HCL Sends First Surgically Excised Ovarian Cancer Tumors to BioVaxys for BVX-0918 Vaccine Process Development

VANCOUVER, BC, June 15, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today that its clinical study collaborator Hospices Civils de Lyon in France ("HCL") has surgically excised the first ovarian cancer tumors from cancer...read article.

Covid testing

https://www.swansonreed.com/inotiv-inc-to-evaluate-biovaxys-covidth/  rate and reply

Eguity guru

https://equity.guru/2022/06/10/the-millennial-sweet-tooth-sector-roundup-week-10/  rate and reply

Article in France this morning-BIOV

https://www.lequotidiendumedecin.fr/specialites/cancerologie/lyon-fait-le-choix-de-lhaptenisation-pour-un-candidat-developpe-avec-biovaxys  rate and reply

Interview

https://m.youtube.com/watch?v=xoJk7UC6jns  rate and reply

.125 other market bid ask

14:09:51 O 0.125 0.015 5,000 1 Anonymous Ask 0.145 11,500 1 0.14 3,000 1 ...read more
The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >